CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $5,999,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$5,999,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-16 | Carter Jennifer L. Director | Purchase | +10,500 | $0.95 | $10K | 30,500 |
| 2022-08-15 | Carter Jennifer L. Director | Grant or award | +10,000 | 20,000 | ||
| 2022-08-15 | Carter Jennifer L. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2022-06-24 | Carter Jennifer L. Director | Exercise or conversion | +10,000 | 10,000 | ||
| 2022-06-24 | Carter Jennifer L. Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2021-06-24 | Carter Jennifer L. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | Carter Jennifer L. Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 |
Page 1 of 1 · 7 trades